LYB vs PCRX · P/E 21, rev $16.37B vs P/E 174, rev $369.8M
LyondellBasell Industries NV (LYB) versus Pacira BioSciences, Inc. (PCRX) — a side-by-side from cached financials, not a winner call.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
LYB currently screens at market cap $19.93B and trailing P/E 21.5. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
Not investment advice. Open the LYB and PCRX stock pages for the full models.
Not investment advice.